Clinical Trials

Inclusion Criteria:

• All eligible patients will be seen by a musculoskeletal oncology surgeons at one of the participating sites.

• All adult patients (≥18 years) diagnosed with bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone undergoing operative tumor resection are eligible. The disease must be localized with no metastases at the time of diagnosis. Tumors can be primary or recurrent, and can be located in the pelvis, lower extremities, or upper extremities.

• Patient must speak English and have an iPhone to be included in the study.

Exclusion Criteria:

• Patients with metastatic bone disease, benign tumors, atypical lipomatous tumors, and dermatofibrosarcoma protuberans will be excluded.

• Patients with metastases at the time of diagnosis will be excluded.

• Pregnant patients and patients unwilling or unable to attend all follow-up evaluations will be excluded.

• Lastly, patients with significant cognitive impairment or communication barriers that prevent informed consent and independent completion of study questionnaires will be excluded.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/16/2025. Questions regarding updates should be directed to the study team contact.